Bryan L Walker1, Christina Williamson2, Shawn M Regis3, Andrea B McKee3, Richard S D'Agostino4, Paul J Hesketh5, Carla R Lamb6, Sebastian Flacke7, Christoph Wald7, Brady J McKee7. 1. Tufts University School of Medicine, Boston, Massachusetts. 2. Department of Cardiovascular and Thoracic Surgery, Lahey Hospital & Medical Center, Burlington, Massachusetts. Electronic address: christina.williamson@lahey.org. 3. Department of Radiation Oncology, Lahey Hospital & Medical Center, Burlington, Massachusetts. 4. Department of Cardiovascular and Thoracic Surgery, Lahey Hospital & Medical Center, Burlington, Massachusetts. 5. Department of Hematology and Oncology, Lahey Hospital & Medical Center, Burlington, Massachusetts. 6. Department of Pulmonary and Critical Care Medicine, Lahey Hospital & Medical Center, Burlington, Massachusetts. 7. Department of Radiology, Lahey Hospital & Medical Center, Burlington, Massachusetts.
Abstract
BACKGROUND: Lung cancer screening with low-dose computed tomography is proven to reduce lung cancer mortality among high-risk patients. However, critics raise concern over the potential for unnecessary surgical procedures performed for benign disease as a result of screening. We reviewed our outcomes in a large clinical lung cancer screening program to assess the number of surgical procedures done for benign disease, as we believe this is an important quality metric. METHODS: We retrospectively reviewed our surgical outcomes of consecutive patients who underwent low-dose computed tomography lung cancer screening from January 2012 through June 2014 using a prospectively collected database. All patients met the National Comprehensive Cancer Network lung cancer screening guidelines high-risk criteria. RESULTS: There were 1,654 screened patients during the study interval with clinical follow-up at Lahey Hospital & Medical Center. Twenty-five of the 1,654 (1.5%) had surgery. Five of 25 had non-lung cancer diagnoses: 2 hamartomas, 2 necrotizing granulomas, and 1 breast cancer metastasis. The incidence of surgery for non-lung cancer diagnosis was 0.30% (5 of 1,654), and the incidence of surgery for benign disease was 0.24% (4 of 1,654). Twenty of 25 had lung cancer, 18 early stage and 2 late stage. There were no surgery-related deaths, and there was 1 major surgical complication (4%) at 30 days. CONCLUSIONS: The incidence of surgical intervention for non-lung cancer diagnosis was low (0.30%) and is comparable to the rate reported in the National Lung Screening Trial (0.62%). Surgical intervention for benign disease was rare (0.24%) in our experience.
BACKGROUND:Lung cancer screening with low-dose computed tomography is proven to reduce lung cancer mortality among high-risk patients. However, critics raise concern over the potential for unnecessary surgical procedures performed for benign disease as a result of screening. We reviewed our outcomes in a large clinical lung cancer screening program to assess the number of surgical procedures done for benign disease, as we believe this is an important quality metric. METHODS: We retrospectively reviewed our surgical outcomes of consecutive patients who underwent low-dose computed tomography lung cancer screening from January 2012 through June 2014 using a prospectively collected database. All patients met the National Comprehensive Cancer Network lung cancer screening guidelines high-risk criteria. RESULTS: There were 1,654 screened patients during the study interval with clinical follow-up at Lahey Hospital & Medical Center. Twenty-five of the 1,654 (1.5%) had surgery. Five of 25 had non-lung cancer diagnoses: 2 hamartomas, 2 necrotizing granulomas, and 1 breast cancer metastasis. The incidence of surgery for non-lung cancer diagnosis was 0.30% (5 of 1,654), and the incidence of surgery for benign disease was 0.24% (4 of 1,654). Twenty of 25 had lung cancer, 18 early stage and 2 late stage. There were no surgery-related deaths, and there was 1 major surgical complication (4%) at 30 days. CONCLUSIONS: The incidence of surgical intervention for non-lung cancer diagnosis was low (0.30%) and is comparable to the rate reported in the National Lung Screening Trial (0.62%). Surgical intervention for benign disease was rare (0.24%) in our experience.
Authors: Mitchell S von Itzstein; Arjun Gupta; Kemp H Kernstine; Kristin C Mara; Sahil Khanna; David E Gerber Journal: PLoS One Date: 2020-04-09 Impact factor: 3.240
Authors: Michael G Milligan; Inga T Lennes; Saif Hawari; Melin J Khandekar; Yolonda Colson; Jo-Anne O Shepard; Angela Frank; Lecia V Sequist; Henning Willers; Florence K Keane Journal: JAMA Netw Open Date: 2022-03-01
Authors: Jennifer A Lewis; Lauren R Samuels; Jason Denton; Michael E Matheny; Amelia Maiga; Christopher G Slatore; Eric Grogan; Jane Kim; Robert H Sherrier; Robert S Dittus; Pierre P Massion; Laura Keohane; Christianne L Roumie; Sayeh Nikpay Journal: Chest Date: 2022-04-09 Impact factor: 10.262